Invention Grant
- Patent Title: Methods and compositions for modulating the immune system with arginase I
-
Application No.: US15833931Application Date: 2017-12-06
-
Publication No.: US10532086B2Publication Date: 2020-01-14
- Inventor: Gernot Schabbauer , Stephan Bluml , Emine Sahin-Heco , Paul Cheng , Li Chen
- Applicant: Bio-Cancer Treatment International Limited
- Applicant Address: HK Shatin
- Assignee: BIO-CANCER TREATMENT INTERNATIONAL LIMITED
- Current Assignee: BIO-CANCER TREATMENT INTERNATIONAL LIMITED
- Current Assignee Address: HK Shatin
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K38/50
- IPC: A61K38/50 ; A61K47/60 ; C12N9/78 ; A61K9/00

Abstract:
Methods and compositions comprising recombinant Arginase I proteins which are capable of depleting the plasma arginine levels in a subject are disclosed. The methods and compositions can be used to modulate the activity of the immune system in a subject. Modulation of the immune system is useful in the treatment of immune disorders and in preventing rejection of a transplanted organ, tissue, or cell. The methods and compositions can also be used to treat a bone condition of a subject.
Public/Granted literature
- US20180085440A1 METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM WITH ARGINASE I Public/Granted day:2018-03-29
Information query
IPC分类: